Section Arrow
Quote
ALGS.NASDAQ
- Aligos Therapeutics Inc
Quotes are at least 15-min delayed:2025/03/28 08:23 EDT
Last
 9.66
0 (0.00%)
Day High 
9.7378 
Prev. Close
9.66 
1-M High
18.6147 
Volume 
99.72K 
Bid
9.07
Ask
12
Day Low
9.1377 
Open
9.39 
1-M Low
9.51 
Market Cap 
59.06M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 11.02 
20-SMA 12.26 
50-SMA 20.23 
52-W High 46.8 
52-W Low 6.76 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-20.94/-1.43
Enterprise Value
63.98M
Balance Sheet
Book Value Per Share
-4.74
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.95M
Operating Revenue Per Share
2.68
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed：2025/03/28 08:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.